Developing new treatments for Alzheimer's disease
TREAT AD
This study is working to find new ways to treat and diagnose Alzheimer's disease by teaming up with different organizations to share helpful information, so that patients can eventually have better treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10954111 on NIH RePORTER |
What this research studies
This research focuses on identifying and validating new therapeutic and diagnostic targets for Alzheimer's disease (AD) to accelerate the development of effective treatments. The project utilizes an open science approach, collaborating with various institutions to gather and share evidence that supports the integration of new drug targets into discovery programs. By creating and disseminating experimental tools and data, the research aims to enhance the understanding of emerging therapeutic hypotheses and facilitate the drug discovery process for AD. Patients may benefit from advancements in treatment options as a result of this collaborative effort.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for Alzheimer's disease, improving patient outcomes.
How similar studies have performed: Previous research initiatives using open science approaches have shown promise in accelerating drug discovery for Alzheimer's disease, indicating a potential for success in this novel approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Levey, Allan I — Emory University
- Study coordinator: Levey, Allan I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.